| J0897 | Injection, denosumab, 1 mg | 15,060 | $20 | $271.1K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,630 | $30 | $152.6K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 9,870 | $10 | $79K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 690 | $100 | $65.8K |
| J1306 | Injection, inclisiran, 1 mg | 3,690 | $10 | $33.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,010 | $30 | $26.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 300 | $60 | $18.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 160 | $110 | $17.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 300 | $50 | $14.7K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 350 | $40 | $12.3K |